In a major study, researchers have revealed that nearly a quarter of the world's population may not have access to a Covid-19 vaccine until at least 2022.

The findings, published in the journal The BMJ, suggest that the operational challenges of the global Covid-19 vaccination programme will be at least as difficult as the scientific challenges associated with their development.